$642 Million is the total value of Soleus Capital Management, L.P.'s 72 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 69.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCAB | Sell | BIOATLA INC | $74,054,000 | -37.5% | 2,515,424 | -10.0% | 11.54% | -36.6% |
| CCCC | Sell | C4 THERAPEUTICS INC | $33,538,000 | +1.8% | 750,633 | -13.8% | 5.23% | +3.1% |
| LNTH | Buy | LANTHEUS HLDGS INC | $31,582,000 | +25.1% | 1,229,827 | +34.6% | 4.92% | +26.7% |
| New | DICE THERAPEUTICS INC | $28,817,000 | – | 879,903 | +100.0% | 4.49% | – | |
| THTX | Buy | THERATECHNOLOGIES INC | $28,546,000 | +4.7% | 7,612,383 | +8.3% | 4.45% | +6.1% |
| NPCE | Buy | NEUROPACE INC | $26,472,000 | -19.6% | 1,670,136 | +20.6% | 4.12% | -18.6% |
| EPIX | Buy | ESSA PHARMA INC | $22,944,000 | -64.1% | 2,868,023 | +28.1% | 3.58% | -63.6% |
| SRDX | Buy | SURMODICS INC | $21,213,000 | +40.5% | 381,522 | +37.0% | 3.31% | +42.3% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $19,183,000 | +28.0% | 319,396 | +27.7% | 2.99% | +29.7% |
| EDAP | Buy | EDAP TMS S Asponsored adr | $18,862,000 | +3.3% | 2,956,367 | +14.7% | 2.94% | +4.6% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $18,790,000 | – | 101,800 | +100.0% | 2.93% | – |
| ISEE | Sell | IVERIC BIO INC | $17,751,000 | +0.2% | 1,093,020 | -61.1% | 2.77% | +1.5% |
| NTRA | Buy | NATERA INC | $15,489,000 | +34.0% | 138,989 | +36.5% | 2.41% | +35.8% |
| IRMD | Sell | IRADIMED CORP | $15,138,000 | +3.5% | 450,679 | -9.4% | 2.36% | +4.9% |
| SIEN | Buy | SIENTRA INC | $13,672,000 | +17.5% | 2,386,063 | +63.3% | 2.13% | +19.1% |
| FLXN | New | FLEXION THERAPEUTICS INC | $12,713,000 | – | 2,084,050 | +100.0% | 1.98% | – |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $10,362,000 | – | 182,400 | +100.0% | 1.62% | – |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $10,322,000 | -38.2% | 92,214 | -10.6% | 1.61% | -37.4% |
| CVRX | Buy | CVRX INC | $10,239,000 | -14.2% | 619,065 | +45.2% | 1.60% | -13.1% |
| HOWL | WEREWOLF THERAPEUTICS INC | $9,668,000 | -1.6% | 563,396 | 0.0% | 1.51% | -0.3% | |
| NEO | Sell | NEOGENOMICS INC | $9,192,000 | -42.2% | 190,556 | -45.9% | 1.43% | -41.4% |
| ORGO | New | ORGANOGENESIS HLDGS INC | $9,112,000 | – | 639,887 | +100.0% | 1.42% | – |
| PCVX | Sell | VAXCYTE INC | $9,023,000 | +6.7% | 355,650 | -5.3% | 1.41% | +8.2% |
| Sell | GOSSAMER BIO INCnote 5.000% 6/0 | $8,432,000 | -1.9% | 8,200,000 | -23.4% | 1.31% | -0.6% | |
| CDNA | Buy | CAREDX INC | $8,027,000 | +199.3% | 126,661 | +332.3% | 1.25% | +203.6% |
| NRIX | New | NURIX THERAPEUTICS INC | $7,906,000 | – | 263,900 | +100.0% | 1.23% | – |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $7,583,000 | +55.5% | 265,700 | +84.1% | 1.18% | +57.6% |
| INSP | Buy | INSPIRE MED SYS INC | $7,208,000 | +73.1% | 30,950 | +43.6% | 1.12% | +75.5% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $6,554,000 | +42.7% | 125,529 | +85.9% | 1.02% | +44.6% |
| CTSO | New | CYTOSORBENTS CORP | $6,496,000 | – | 800,000 | +100.0% | 1.01% | – |
| ANGO | New | ANGIODYNAMICS INC | $6,291,000 | – | 242,525 | +100.0% | 0.98% | – |
| GLPG | New | GALAPAGOS NVspon adr | $6,066,000 | – | 115,300 | +100.0% | 0.94% | – |
| ITMR | Sell | ITAMAR MED LTDsponsored ads | $5,465,000 | -56.3% | 180,839 | -65.9% | 0.85% | -55.7% |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $5,246,000 | -66.6% | 201,994 | -78.4% | 0.82% | -66.2% |
| New | SOMALOGIC INC | $5,232,000 | – | 422,243 | +100.0% | 0.82% | – | |
| VNDA | New | VANDA PHARMACEUTICALS INC | $5,118,000 | – | 298,600 | +100.0% | 0.80% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $5,112,000 | – | 210,815 | +100.0% | 0.80% | – |
| EOLS | Buy | EVOLUS INC | $4,899,000 | -33.2% | 642,934 | +10.9% | 0.76% | -32.4% |
| AVIR | New | ATEA PHARMACEUTICALS INC | $4,123,000 | – | 117,600 | +100.0% | 0.64% | – |
| ASMB | ASSEMBLY BIOSCIENCES INC | $3,905,000 | -10.3% | 1,122,000 | 0.0% | 0.61% | -9.0% | |
| PIRS | New | PIERIS PHARMACEUTICALS INC | $3,826,000 | – | 740,000 | +100.0% | 0.60% | – |
| CMPS | COMPASS PATHWAYS PLCsponsored ads | $3,816,000 | -21.7% | 127,743 | 0.0% | 0.60% | -20.6% | |
| PCRX | New | PACIRA BIOSCIENCES INC | $3,696,000 | – | 66,000 | +100.0% | 0.58% | – |
| New | DA32 LIFE SCNCE TEC ACQSTN C | $3,441,000 | – | 350,000 | +100.0% | 0.54% | – | |
| ARNA | New | ARENA PHARMACEUTICALS INC | $3,382,000 | – | 56,800 | +100.0% | 0.53% | – |
| XENE | Sell | XENON PHARMACEUTICALS INC | $3,296,000 | -24.2% | 215,697 | -7.7% | 0.51% | -23.2% |
| INBX | Sell | INHIBRX INC | $3,264,000 | -51.2% | 97,979 | -59.6% | 0.51% | -50.5% |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $3,261,000 | +34.4% | 120,900 | +19.9% | 0.51% | +36.2% |
| NVCR | Sell | NOVOCURE LTD | $3,169,000 | -85.6% | 27,275 | -72.4% | 0.49% | -85.4% |
| LUNG | Buy | PULMONX CORP | $3,152,000 | -16.2% | 87,612 | +2.8% | 0.49% | -15.1% |
| VIVO | New | MERIDIAN BIOSCIENCE INC | $3,136,000 | – | 163,000 | +100.0% | 0.49% | – |
| CORT | New | CORCEPT THERAPEUTICS INC | $3,050,000 | – | 155,000 | +100.0% | 0.48% | – |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $3,015,000 | -6.2% | 300,000 | 0.0% | 0.47% | -5.1% | |
| CDMO | New | AVID BIOSERVICES INC | $2,912,000 | – | 135,000 | +100.0% | 0.45% | – |
| DYN | DYNE THERAPEUTICS INC | $2,897,000 | -22.8% | 178,360 | 0.0% | 0.45% | -21.8% | |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $2,725,000 | -14.9% | 1,950,000 | 0.0% | 0.42% | -13.6% | ||
| ZGNX | New | ZOGENIX INC | $2,597,000 | – | 171,000 | +100.0% | 0.40% | – |
| AXGN | AXOGEN INC | $2,499,000 | -26.9% | 158,140 | 0.0% | 0.39% | -25.9% | |
| LYRA | Buy | LYRA THERAPEUTICS INC | $1,967,000 | +33.8% | 215,576 | +17.8% | 0.31% | +35.8% |
| CELC | Sell | CELCUITY INC | $1,506,000 | -61.9% | 83,688 | -49.2% | 0.24% | -61.3% |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,426,000 | -21.6% | 213,519 | 0.0% | 0.22% | -20.7% | |
| BVS | New | BIOVENTUS INC | $1,340,000 | – | 94,602 | +100.0% | 0.21% | – |
| CTMX | New | CYTOMX THERAPEUTICS INC | $1,329,000 | – | 261,050 | +100.0% | 0.21% | – |
| New | ASTRIA THERAPEUTICS INC | $994,000 | – | 112,499 | +100.0% | 0.16% | – | |
| EDIT | Sell | EDITAS MEDICINE INC | $965,000 | -82.2% | 23,500 | -75.4% | 0.15% | -82.0% |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $862,000 | – | 41,000 | +100.0% | 0.13% | – |
| New | PROCEPT BIOROBOTICS CORP | $763,000 | – | 20,000 | +100.0% | 0.12% | – | |
| CUTR | Sell | CUTERA INC | $675,000 | -86.6% | 14,480 | -85.9% | 0.10% | -86.5% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $670,000 | -76.4% | 7,700 | -65.2% | 0.10% | -76.2% |
| RFL | Sell | RAFAEL HLDGS INC | $668,000 | -64.4% | 21,742 | -40.8% | 0.10% | -63.9% |
| GLUE | Sell | MONTE ROSA THERAPEUTICS INC | $557,000 | -67.3% | 25,000 | -66.7% | 0.09% | -66.8% |
| EWTX | EDGEWISE THERAPEUTICS INC | $520,000 | -22.2% | 31,300 | 0.0% | 0.08% | -21.4% | |
| RPTX | Exit | REPARE THERAPEUTICS INC | $0 | – | -7,300 | -100.0% | -0.04% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -86,442 | -100.0% | -0.05% | – |
| NARI | Exit | INARI MED INC | $0 | – | -6,150 | -100.0% | -0.09% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -47,537 | -100.0% | -0.12% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -90,000 | -100.0% | -0.14% | – |
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -31,306 | -100.0% | -0.15% | – |
| RNLX | Exit | RENALYTIX PLCads | $0 | – | -47,300 | -100.0% | -0.22% | – |
| CMAX | Exit | CAREMAX INC | $0 | – | -118,900 | -100.0% | -0.24% | – |
| Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -775,000 | -100.0% | -0.25% | – | |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -44,100 | -100.0% | -0.31% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -17,500 | -100.0% | -0.33% | – |
| MSON | Exit | MISONIX INC | $0 | – | -100,788 | -100.0% | -0.34% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -26,568 | -100.0% | -0.36% | – |
| PODD | Exit | INSULET CORP | $0 | – | -8,980 | -100.0% | -0.38% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -5,884 | -100.0% | -0.39% | – |
| TKNO | Exit | ALPHA TEKNOVA INC | $0 | – | -114,546 | -100.0% | -0.42% | – |
| GLTO | Exit | GALECTO INC | $0 | – | -538,152 | -100.0% | -0.42% | – |
| RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -125,700 | -100.0% | -0.61% | – |
| MDXG | Exit | MIMEDX GROUP INC | $0 | – | -322,160 | -100.0% | -0.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.